Identification of metabolic biomarkers and therapeutic targets in the thymoma-associated myasthenia gravis treated with methylprednisolone

Abstract Objective This study aims to screen and identify metabolic biomarkers and targets for methylprednisolone treatment of thymoma with myasthenia gravis (MG) through metabolomics and network pharmacology analysis, thereby improving guidance for clinical medication and treatment. Methods Serum f...

Full description

Bibliographic Details
Published in:Discover Oncology
Main Authors: Shanshan Gu, Xu Wang, Hongxia Yang, Yaxuan Wang, Congya Yan, Xiaoting Lin, Peng Liu, Lu Liu, Li Meng, Guoyan Qi
Format: Article
Language:English
Published: Springer 2025-05-01
Subjects:
Thymoma
Myasthenia gravis
Metabolomics
LC–MS
Network pharmacology
Online Access:https://doi.org/10.1007/s12672-025-02700-2

Internet

https://doi.org/10.1007/s12672-025-02700-2

Similar Items